Lifestyle behaviors, metabolic disturbances, and weight gain in psychiatric inpatients treated with weight gain-associated medication.

"Declarations Conflict of interestRM has carried out studies financed by Janssen-Cilag, Emalex, Böhringer-Ingelheim and has received speaker’s honoraria from Otsuka over the past 3 years. MSS, BB, AZ, KE, LR, and CG declare no potential conflict of interest. Ethical approvalThe study was approved by the ethics committee of the medical faculty of the Ludwig-Maximilians-University (reference number 290.14) and conducted in accordance with the principles of good clinical practice and the Declaration of Helsinki and its subsequent revisions. Consent to participateAll participants provided written informed consent prior to study inclusion. Consent for publicationNot applicable. Conflict of interest RM has carried out studies financed by Janssen-Cilag, Emalex, Böhringer-Ingelheim and has received speaker’s honoraria from Otsuka over the past 3 years. MSS, BB, AZ, KE, LR, and CG declare no potential conflict of interest."

"Funding Open Access funding enabled and organized by Projekt DEAL. This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors."